comparemela.com

Page 2 - ஸ்கைஹாக் சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aragen Announces Partnership with Skyhawk Therapeutics, Aimed at Developing Novel Small Molecule Therapeutics that Correct RNA Expression

Aragen Announces Partnership with Skyhawk Therapeutics, Aimed at Developing Novel Small Molecule Therapeutics that Correct RNA Expression
cadillacnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cadillacnews.com Daily Mail and Mail on Sunday newspapers.

Virtual Screening Series Continues This Weekend With Documentary

The Woods Hole Film Festival will continue its 2021 series of virtual programming with the feature documentary “Jim Allison: Breakthrough” by Bill Haney, narrated by Woody Harrelson, Thursday, May 6 through Sunday, May 9. The festival will host a live online line question and answer session with the filmmakers on Saturday, May 8, at 7 PM. The film will be available to watch between Thursday, May 6 at 8 AM and Sunday, May 9 at midnight. A free ticket to the virtual question and answer session will be made available at ticket purchase. Once home viewing is started, viewers will have 48 hours to finish watching, or until midnight on Sunday, May 9, whichever comes first.

Skyhawk Therapeutics Expands Leadership Team, Appointing Elliot Ehrich MD as President and Graeme Smith PhD as SVP NonClinical Development

Skyhawk Therapeutics Expands Leadership Team, Appointing Elliot Ehrich MD as President and Graeme Smith PhD as SVP NonClinical Development News provided by Share this article Share this article Elliot Ehrich MD brings 25+ years R&D and clinical development leadership experience to the company; Graeme Smith PhD DABT brings 15+ years of nonclinical drug development leadership experience to the company. WALTHAM, Mass., April 13, 2021 /PRNewswire/  Skyhawk Therapeutics today announced the appointments of Dr. Elliot Ehrich as its President, and Dr. Graeme Smith as its Senior Vice President of Nonclinical Development. Skyhawk builds novel small molecule RNA modifying drug candidates for deployment across a wide range of oncology, neurology and autoimmune diseases.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.